For example, MRI-based midbrain-to-pons (M/P) ratios below 0.52 and elevated levels of plasma or CSF neurofilament light chain (NfL) can help distinguish PSP from PD and multiple system atrophy (MSA), even in early or clinically ambiguous cases [36]. This evidence concerns the gene NEFL and Parkinson disease.